相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。COVID-19 and Lung Mast Cells: The Kallikrein-Kinin Activation Pathway
Seigo Nagashima et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Bradykinin-target therapies in SARS-CoV-2 infection: current evidence and perspectives
Manuele Figueiredo da Silva et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2022)
A comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseases
Devasahayam Arokiar Balaya Rex et al.
MOLECULAR BIOLOGY REPORTS (2022)
KLK6/PAR1 Axis Promotes Tumor Growth and Metastasis by Regulating Cross-Talk between Tumor Cells and Macrophages
Yo Sep Hwang et al.
CELLS (2022)
The family of kallikrein-related peptidases and kinin peptides as modulators of epidermal homeostasis
Carola E. Matus et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2022)
Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19
Caroline P. Martens et al.
EBIOMEDICINE (2022)
Remodelling of the tumour microenvironment by the kallikrein-related peptidases
Srilakshmi Srinivasan et al.
NATURE REVIEWS CANCER (2022)
A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications
Cameron G. McCarthy et al.
VASCULAR PHARMACOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Tissue factor pathway inhibitor 2 is a potent kallikrein-related protease 12 inhibitor
Marion Lavergne et al.
BIOLOGICAL CHEMISTRY (2021)
Current and Future Development in Lung Cancer Diagnosis
Reem Nooreldeen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Toward personalized treatment approaches for non-small-cell lung cancer
Meina Wang et al.
NATURE MEDICINE (2021)
Reversal of pulmonary arterial hypertension and neointimal formation by kinin B1 receptor blockade
Dileep Reddy Rampa et al.
RESPIRATORY RESEARCH (2021)
MicroRNA-378-3p/5p suppresses the migration and invasiveness of oral squamous carcinoma cells by inhibiting KLK4 expression
Zhi Cui et al.
BIOCHEMISTRY AND CELL BIOLOGY (2020)
COVID-19 cytokine storm: The anger of inflammation
Mehdi Mahmudpour et al.
CYTOKINE (2020)
A lesson from a saboteur: High-MW kininogen impact in coronavirus-induced disease 2019
Chiara Colarusso et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm
Michael R. Garvin et al.
ELIFE (2020)
Involvement of Kallikrein-Related Peptidases in Nervous System Disorders
Cinthia Mella et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma
Honghai Ma et al.
SCIENTIFIC REPORTS (2019)
THE NEUTROPHIL'S ROLE DURING HEALTH AND DISEASE
Pei Xiong Liew et al.
PHYSIOLOGICAL REVIEWS (2019)
CASC15 contributes to proliferation and invasion through regulating miR-766-5p/ KLK12 axis in lung cancer
Yong Bai et al.
CELL CYCLE (2019)
Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line
Jun Lu et al.
FRONTIERS IN ONCOLOGY (2019)
Tissue ACE phenotyping in lung cancer
Sergei M. Danilov et al.
PLOS ONE (2019)
Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg(9) bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration
Chhinder P. Sodhi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer
Carlos D. Figueroa et al.
BIOLOGICAL CHEMISTRY (2018)
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types
Prashant D. Tailor et al.
Oncotarget (2018)
Progress and prospects of early detection in lung cancer
Sean Blandin Knight et al.
OPEN BIOLOGY (2017)
The kallikrein-related peptidase family: Dysregulation and functions during cancer progression
T. Kryza et al.
BIOCHIMIE (2016)
Kallikrein-related peptidases (KLKs) and the hallmarks of cancer
Panagiota S. Filippou et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2016)
Identification of vitamin D3 target genes in human breast cancer tissue
Lei Sheng et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
Is Human Kallikrein 11 in Non-small Cell Lung Cancer Treated Chemoradiotherapy Associated with Survival?
Dilek Unal et al.
CANCER RESEARCH AND TREATMENT (2016)
Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges
Vittore Cereda et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Expression and bioregulation of the kallikrein-related peptidases family in the human neutrophil
Alejandro J. Lizama et al.
INNATE IMMUNITY (2015)
Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer
Fabien Gueugnon et al.
TUMOR BIOLOGY (2015)
In Vivo Radioimaging of Bradykinin Receptor B1, a Widely Overexpressed Molecule in Human Cancer
Kuo-Shyan Lin et al.
CANCER RESEARCH (2015)
Dual Targeting of the Androgen Receptor and Hypoxia-Inducible Factor 1α Pathways Synergistically Inhibits Castration-Resistant Prostate Cancer Cells
Elena V. Fernandez et al.
MOLECULAR PHARMACOLOGY (2015)
Growth and survival of lung cancer cells: regulation by kallikrein-related peptidase 6 via activation of proteinase-activated receptor 2 and the epidermal growth factor receptor
Noemie Michel et al.
BIOLOGICAL CHEMISTRY (2014)
Bradykinin antagonists and thiazolidinone derivatives as new potential anti-cancer compounds
Stanislav Avdieiev et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
The diagnostic and prognostic value of serum human kallikrein-related peptidases 11 in non-small cell lung cancer
Chun-Hua Xu et al.
TUMOR BIOLOGY (2014)
Pro-angiogenic effect of human kallikrein-related peptidase 12 (KLK12) in lung endothelial cells does not depend on kinin-mediated activation of B2 receptor
Thomas Kryza et al.
BIOLOGICAL CHEMISTRY (2013)
The potential of carboxypeptidase M as a therapeutic target in cancer
Catherine J. Denis et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Evolution of the Plasma and Tissue Kallikreins, and Their Alternative Splicing Isoforms
Vassiliki Lila Koumandou et al.
PLOS ONE (2013)
Kinin receptors as targets for cancer therapy
Carlos D. Figueroa et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Targeting the kallikrein-related peptidases for drug development
Georgia Sotiropoulou et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Epigenetic activation of human kallikrein 13 enhances malignancy of lung adenocarcinoma by promoting N-cadherin expression and laminin degradation
Ruey-Hwang Chou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Pentraxin-3 Is a Novel Biomarker of Lung Carcinoma
Eleftherios P. Diamandis et al.
CLINICAL CANCER RESEARCH (2011)
Kallikrein-related Peptidase 12 Hydrolyzes Matricellular Proteins of the CCN Family and Modifies Interactions of CCN1 and CCN5 with Growth Factors
Audrey Guillon-Munos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Alternative Splicing Variant of Kallikrein-Related Peptidase 8 as an Independent Predictor of Unfavorable Prognosis in Lung Cancer
Chris Planque et al.
CLINICAL CHEMISTRY (2010)
Kallikreins on Steroids: Structure, Function, and Hormonal Regulation of Prostate-Specific Antigen and the Extended Kallikrein Locus
Mitchell G. Lawrence et al.
ENDOCRINE REVIEWS (2010)
Strong cytotoxic effect of the bradykinin antagonist BKM-570 in ovarian cancer cells - analysis of the molecular mechanisms of its antiproliferative action
Stephanie Jutras et al.
FEBS JOURNAL (2010)
Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer
Youwei Zhang et al.
CANCER SCIENCE (2009)
Functional Roles of Human Kallikrein-related Peptidases
Georgia Sotiropoulou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis
Nathalie Heuze-Vourc'h et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Identification of Five Candidate Lung Cancer Biomarkers by Proteomics Analysis of Conditioned Media of Four Lung Cancer Cell Lines
Chris Planque et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung
Chris Planque et al.
BIOLOGICAL CHEMISTRY (2008)
Kallikreins and proteinase-mediated signalling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory disease and cancer
Morley D. Hollenberg et al.
BIOLOGICAL CHEMISTRY (2008)
Expression of tissue and plasma kallikreins and kinin B1 and B2 receptors in lung cancer
Jessica Chee et al.
BIOLOGICAL CHEMISTRY (2008)
A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma
Chris Planque et al.
CLINICAL CANCER RESEARCH (2008)
Expression of kallikrein-related peptidases (KRP/hK5, 7, 6, 8) in subtypes of human lung carcinoma
Jasmine Singh et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
The presence of carboxypeptidase-M in tumour cells signifies epidermal growth factor receptor expression in lung adenocarcinomas
Ioannis Tsakiris et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness
Yuh-Pyng Sher et al.
CANCER RESEARCH (2006)
Decreased kallikrein 11 messenger RNA expression in lung cancer
Hidefumi Sasaki et al.
CLINICAL LUNG CANCER (2006)
Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues
Chris Planque et al.
BIOLOGICAL CHEMISTRY (2006)
Cellular distribution of human tissue kallikreins: immunohistochemical localization
Constantina D. Petralki et al.
BIOLOGICAL CHEMISTRY (2006)
Peptide and non-peptide bradykinin receptor antagonists: Role in allergic airway disease
WM Abraham et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
KLK5 and KLK7, two members of the human tissue, kallikrein family, are differentially expressed in lung cancer
C Planque et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
New lung cancer drugs from bradykinin antagonists
JM Stewart et al.
CHEST (2004)
Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a biased agonist mechanism
D Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Bradykinin-related compounds as new drugs for cancer and inflammation
JM Stewart et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2002)
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
A Bhattacharjee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The mRNAs of prekallikrein, factors XI and XII, and kininogen, components of the contact phase cascade are differentially expressed in multiple non-hepatic human tissues
P Neth et al.
THROMBOSIS AND HAEMOSTASIS (2001)
The new human kallikrein gene family: Implications in carcinogenesis
EP Diamandis et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2000)
分享论文
